Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target
1
x
$
30.00
Mark S. Bauer, MD: Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide
1
x
$
30.00
Gwenn S. Smith, PhD: Applications of Neuroreceptor Imaging to Psychiatry Research
1
x
$
30.00
Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
1
x
$
0.00
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
1
x
$
30.00
Managing Deep Vein Thrombosis Risk in Oncology Patients Office and Outpatient Settings
1
x
$
10.00
Husseini K. Manji, MD, FRCPC: Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics
1
x
$
30.00
Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit
1
x
$
30.00
Madhukar H. Trivedi - Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design
1
x
$
30.00
View Cart
Checkout
Home
Store
“Madhukar H. Trivedi – Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide
$
30.00
Add to cart
Details
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS)
$
0.00
Add to cart
Details
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
$
0.00
Add to cart
Details
A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder
$
30.00
Add to cart
Details
A Pilot Evaluating Clinical Pharmacy Services in an Ambulatory Psychiatry Setting
$
30.00
Add to cart
Details
A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach
$
30.00
Add to cart
Details
A Pilot Study to Explore the Effect of Long Acting Injectable Antipsychotics on Aggression
$
30.00
Add to cart
Details
A Placebo-Controlled Trial of Guanfacine for the Treatment of Posttraumatic Stress Disorder in Veterans
$
30.00
Add to cart
Details
A Prospective Surveillance of Pharmacovigilance of Psychotropic Medicines in a Developing Country
$
30.00
Add to cart
Details
A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5–12
$
30.00
Add to cart
Details
A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder
$
30.00
Add to cart
Details
A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae
$
30.00
Add to cart
Details
A Systematic Approach to Improving Care for Cancer Patients: Focus on Growth Factor Use and Outcomes
$
0.00
Add to cart
Details
A Systematic Review of Augmentation Strategies for Major Depressive Disorder
$
30.00
Add to cart
Details
A Unique Delusion with Depression in Early Stage of Neurocognitive Disorder Due to Vascular Disease: Considerations for Clinicians
$
30.00
Add to cart
Details
Addressing Methodological Issues in Studying Antidepressant Onset Efficacy Using Prespecified Sensitivity Analyses
$
30.00
Add to cart
Details
ADHD and Drug Holidays: Effects on Anthropometric Changes during Methylpenidate Treatment
$
30.00
Add to cart
Details
ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas!
$
30.00
Add to cart
Details
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
$
30.00
Add to cart
Details
Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial
$
30.00
Add to cart
Details
Previous
1
2
3
…
44
Next
Page load link
Go to Top
